Recently, a study clearly showed that hepatocellular carcinoma cells overexpressing SerpinB3 are more resistant to Sor treatment, and was associated with the activation of caspase signaling [31]. This evidence concerns the gene SERPINB3 and hepatocellular carcinoma.